HealthEquity (HQY) Tops Q4 EPS by 5c, Beats on Revenue; Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.95, $0.05 better than the analyst estimate of $0.90. Revenue for the quarter came in at $334.6 million versus the consensus estimate of $331.93 million.

For the fiscal year ending January 31, 2027, management expects revenues of $1.405 billion to $1.415 billion. Its outlook for net income is between $239 million and $246 million, resulting in net income of $2.78 to $2.85 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $392 million and $400 million, resulting in non-GAAP net income per diluted share of $4.56 to $4.65 (based on an estimated 86 million weighted-average shares outstanding). Management expects Adjusted EBITDA of $618 million to $628 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
• A.O. Smith executive chairman to retire, CEO to assume chairman role